Search

Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.

… Monday, November 23, 2020 Summary Genetic mutations that give cancers a metabolic boost may also leave them vulnerable to drugs that promote a particular form of cell death, Sloan Kettering Institute researchers have found. If there is a silver lining in cancer’s chaotic biology, it’s that the same traits

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.

… Wednesday, October 1, 2025 Memorial Sloan Kettering Cancer Center (MSK) presented new research on a range of important topics at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO), held September 27 to October 1 in San Francisco. The presentations included two clinical trials

Get an inside look into the life of a student from the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.

… Tuesday, November 23, 2021 As a student at the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences, you will join the laboratory of one of more than 130 scientists from Memorial Sloan Kettering Cancer Center with expertise in cancer biology, genomics, immunology, structural biology,

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

… Wednesday, August 19, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer

Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.

… Monday, November 7, 2022 Highlights MACHETE is a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models. Using MACHETE, researchers found that a prominent deletion often eliminates a cluster of interferon genes — leading to poorer outcomes in mouse models of

In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation.

… Wednesday, June 9, 2004 Summary In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation. In recognition of his contributions

Everyone knows that cigarettes cause cancer. But what do we know about how they do it?

… Friday, December 7, 2018 Summary Scientists are learning how the carcinogens in cigarette smoke interact with DNA to promote cancer. This molecular information complements the well-known epidemiological links between smoking and cancer. That cigarettes cause cancer is no secret. In addition to about

Leptomeningeal metastasis, cancer that has spread to the areas surrounding the brain and spinal cord, has long been a formidable clinical challenge for oncologists. Researchers at Memorial Sloan Kettering Cancer Center have identified the molecular basis of this increasingly prevalent complication of cancer. With the help of a mouse model, researchers have identified a drug strategy that may combat this virtually untreatable condition. This research by Joan Massagué, PhD, Adrienne Boire, MD, PhD, and colleagues, was published in the March 9, 2017 issue of Cell. For more information on this work and to speak with the study authors, contact [email protected].

… Thursday, March 9, 2017 Bottom Line: Leptomeningeal metastasis, cancer that has spread to the areas surrounding the brain and spinal cord, has long been a formidable clinical challenge for oncologists. Researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified the molecular basis of

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

… Tuesday, September 4, 2012 Summary In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors. A recent study by Memorial Sloan Kettering researchers is a step in the direction of improving strategies to find matching

An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies.

… Thursday, November 10, 2022 An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies. Moments after getting bad news about her lung cancer , Joyce Tyson